MedPath

The efficacy of Sodium tetradecyl sulfate 1% and Ceftazidime and Metronidazole in perianal fistula

Phase 2
Completed
Conditions
Anal fistula.
Anal fistula
Registration Number
IRCT2013051913385N1
Lead Sponsor
Ahvaz Jondishapur University of Medical Sciences, Vice Chancellor for Research and Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
22
Inclusion Criteria

all patients with perianal fistula.
Exclusion criteria: Pregnant or nursing women and patients with severe systemic disease.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disappear of fistula tract. Timepoint: Six months after beginning of intervention. Method of measurement: Physical exam with prob.
Secondary Outcome Measures
NameTimeMethod
Disappear of pain. Timepoint: Six months after beginning of intervention. Method of measurement: History.;Disappear of discharge. Timepoint: Six months after beginning of intervention. Method of measurement: History and Physical exam.
© Copyright 2025. All Rights Reserved by MedPath